‘Quick, nice, great’: 5 cancer patients test Hong Kong-made ‘living drug’
A new "living drug" produced in Hong Kong has shown promising results in treating lymphoma patients, with retiree Li Chun experiencing significant improvement after years of unsuccessful treatments. The CAR-T therapy, developed by the Chinese University of Hong Kong (CUHK), led to the disappearance of cancerous tumors in Li Chun, offering her a pain-free and improved quality of life.
Li Chun was among the first five Hong Kong cancer patients to participate in the clinical trial using locally manufactured CAR-T products. The therapy involves modifying a patient's own T-cells to target and destroy cancer cells. Early results indicate that all five patients, including children and adults, are doing well, with most being discharged from the hospital within a month of receiving the CAR-T infusion, marking a significant advancement in cancer treatment in the region.
via SCMP Full Text Feed
A new "living drug" produced in Hong Kong has shown promising results in treating lymphoma patients, with retiree Li Chun experiencing significant improvement after years of unsuccessful treatments. The CAR-T therapy, developed by the Chinese University of Hong Kong (CUHK), led to the disappearance of cancerous tumors in Li Chun, offering her a pain-free and improved quality of life.
Li Chun was among the first five Hong Kong cancer patients to participate in the clinical trial using locally manufactured CAR-T products. The therapy involves modifying a patient's own T-cells to target and destroy cancer cells. Early results indicate that all five patients, including children and adults, are doing well, with most being discharged from the hospital within a month of receiving the CAR-T infusion, marking a significant advancement in cancer treatment in the region.
via SCMP Full Text Feed
